Carcinomatous Meningitis Active Not Recruiting Phase 1 / 2 Trials for Trastuzumab (DB00072)

IndicationStatusPhase
DBCOND0052638 (Carcinomatous Meningitis)Active Not Recruiting1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01373710Intrathecal Trastuzumab Administration in Metastatic Breast Cancer Patients Developing Carcinomatous MeningitisTreatment